| Disease | THE EFFECTS OF CAPSULES CONTAINING 60 MG OF A STANDARDIZED EXTRACT OF GINKGO BILOBA (GK501) AND 100 MG OF A STANDARDISE EXTRACT OF PANAX GINSENG (G115) ON VARIOUS ASPECTS OF COGNITIVE FUNCTION WERE ASSESSED IN HEALTHY MIDDLE-AGED VOLUNTEERS. A
DOUBLEBLIND, PLACEBO CONTROLLED, 14 WEEK, PARALLEL GROUP, REPEATED ASSESSMENT, MULTI-CENTRE TRIAL OF TWO DOSING REGIMENS, 160 MG B.I.D. AND 320 MG O.D. WAS CONDUCTED. THE VOLUNTEERS PERFORMED A SELECTION OF TESTS OF ATTENTION AND MEMORY FROM THE
COGNITIVE DRUG RESEARCH COMPUTERISED COGNITIVE ASSESSMENT SYSTEM AND COMPLETED QUESTIONNARIES ABOUT MOOD STATES, QUALITY OF LIFE AND SLEEP QUALITY. THE GINKGO/GINSENG COMBINATION WAS FOUND SIGNIFICANTLY TO IMPROVE AN INDEX OF MEMORY QUALITY,
SUPPORTING A PREVIOUS FINDING WITH THE COMPOUND.
A COMMERCIAL PRODUCT, G115, WAS USED. |